VOR: Prakiraan pendapatan perusahaan Vor Biopharma Inc.

Simbol resmi perusahaan Vor Biopharma, Inc. (VOR)

Vor Biopharma Inc. (VOR) complies with basic environmental standards for biolaboratories. The firm's estimated sales volume reflects current dynamics, with the indicator settling at 0.00. Growth prospects are based on the commercialization of cell therapy and bone marrow protection. Holding genetic patents will provide the company with a long-term monopoly advantage when implementing therapy into medical practice.

Pendapatan mangsa ngarep perusahaan: vorbio.com (VOR) kanggo 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Vor Bio (VOR)

- rega saiki lan proyeksi nilai saham:
Kutipan saham Vor Biopharma|VOR - Bagan rega target
- informasi kapitalisasi pasar:
Nilai pasar Vor Biopharma, Inc.|VOR - Total Nilai Perusahaan
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Vor Biopharma|VOR - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi marang Aset Bersih vorbio.com|VOR - Nilai Agregat Aset
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Vor Biopharma Inc.|VOR - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal vorbio.com|VOR - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Vor Biopharma, Inc.|VOR - Utang jangka dawa|Utang jangka cendhak perusahaan Vor Biopharma|Rasio cepet vorbio.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
VOR - Bathi pungkasan|Proyeksi bathi mangsa ngarep Vor Biopharma Inc.|VOR - Pangali P/E|Rega marang bathi mangsa ngarep Vor Bio|VOR - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vor Biopharma|VOR - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Vor Biopharma|VOR - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan vorbio.com|VOR - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Vor Biopharma Inc.
- informasi babagan volume dodolan lan pendapatan:
VOR - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan Vor Bio|VOR - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S Vor Biopharma|VOR - Wutah pendapatan YoY sajrone 12 wulan kepungkur
Analisis dhasar perusahaan:VOR Vor Bio Inc.
Produk merek Vor Biopharma, Inc.

Investors utilize this indicator for a leading assessment of an asset's fundamental value, minimizing the time lag associated with traditional reporting. The metric is based on daily monitoring of US market data; therefore, the calculated sales level for Vor Biopharma Inc. (VOR) reflects the monetization potential of unique blood cancer therapies which, upon approval, will provide Vor Biopharma Inc. (VOR) with exceptional pricing power in the healthcare market.

Pesaing Vor Biopharma Inc. (VOR)

Prakiraan volume dodolan TGTX|Arcellx, Inc. - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IRON (Disc Medicine, Inc.)|Dodolan mangsa ngarep perusahaan Syndax Pharmaceuticals (SNDX)|KURA: Volume dodolan mangsa ngarep perusahaan|ADCT (ADC Therapeutics) - Prakiraan pendapatan perusahaan|FHTX: Prakiraan volume dodolan|Nkarta Corp (NKTX) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Coeptis|Actinium Corp (ATNM) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan ESLA|CASI (CASI Pharmaceuticals Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Marker Therapeutics MRKR|INAB - Volume dodolan mangsa ngarep perusahaan|ERNA: Volume dodolan mangsa ngarep perusahaan|Pendapatan sing dikarepake perusahaan GTBP|APTO: Prakiraan volume dodolan|Bio-Path Holdings, Inc. - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan MEI Pharma Inc|Vincerx Pharma, Inc. - Pendapatan sing dikarepake perusahaan